Emerald Mutual Fund Advisers Trust’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.27M | Sell |
136,297
-70,738
| -34% | -$3.77M | 0.44% | 84 |
|
|
2025
Q1 | $8.38M | Sell |
207,035
-145,145
| -41% | -$5.88M | 0.59% | 68 |
|
|
2024
Q4 | $9.8M | Sell |
352,180
-63,021
| -15% | -$1.75M | 0.6% | 64 |
|
|
2024
Q3 | $11.9M | Sell |
415,201
-9,700
| -2% | -$278K | 0.62% | 66 |
|
|
2024
Q2 | $9.97M | Hold |
424,901
| – | – | 0.52% | 68 |
|
|
2024
Q1 | $10.7M | Buy |
424,901
+308,820
| +266% | +$7.8M | 0.56% | 77 |
|
|
2023
Q4 | $2.71M | Buy |
+116,081
| New | +$2.71M | 0.14% | 121 |
|